Atlas Trials

A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

Clinical trial NCT00996567 · COMPLETED

Trial details

NCT number
NCT00996567
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2009-10-01
Primary completion
2015-09-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.